QUEBEC CITY.
INVESTING IN A DYNAMIC FUTURE.
Quebec City is the No. 1 low-cost location
among all comparable locations in the Northeast U.S./Canada region –
providing exceptional value to your investment. This impressive result
comes from Competitive Alternatives: KPMG’s Guide to International
Business Costs, 2006 edition. The comprehensive study of location-sensitive
costs compares 128 cities in North America, Europe and Asia-Pacific, using
the U.S. average as the study benchmark. The provincial capital fares
well among the top 10 low-cost G7 locations in nine out of the 17 sectors
KPMG reviewed, including product testing, precision manufacturing, aerospace,
pharmaceuticals, chemicals, telecommunications, biotechnology, clinical
trials and software design.
| 
|
|
LEADING THE PACK
This charming city offers clear cost advantages over all comparable U.S.
locations in the Northeast U.S./Canada region. Quebec City is number two
in the region with an overall cost advantage of 7.4 percentage points
over the U.S. average. It also clinched the number two position in the
region in 11 of the 17 sectors studied. Driven by innovation, Quebec City
enjoys a comfortable 16.3 and 25.1 percentage point cost advantage over
the U.S. average in biotechnology and clinical trials respectively.
MAXIMIZING COST ADVANTAGES
The KPMG study confirms Quebec City’s substantial cost advantages
over U.S. cities. The almost 400-year old city has cost advantages ranging
from 1.5 percentage points over Lexington to 8.3 percentage points over
Buffalo.
That’s just the start. Quebec City has across-the-board
regional cost advantages in each sectoral category analyzed by KPMG as
proven in the graph below:
The cost advantage is clear. The choice is yours. Investing in
Canada simply makes a whole lot of business sense. |
QUEBEC CITY QUICK FACTS:
- Province: Quebec
- Population: 717,600 (2005)
- Traditional Industries: Forestry and wood products,
insurance and financial services, and tourism.
- Emerging Industries: Chemicals and plastics, information
and communications technology, and life sciences.
|
|